A new study suggests that a genetic switch that causes latent HIV inside cells to begin to replicate can be manipulated to completely eradicate the virus from the human body. Cells harboring latent HIV are “invisible” to the natural defenses of the immune system. The findings, which suggest a cure for HIV may be possible, […]Continue Reading ...
Home News Professional More People Worldwide Now Know Their HIV Status MONDAY, Dec. 3, 2018 — Three-quarters of patients living with HIV worldwide know their infection status, according to Knowledge Is Power, a new report released Nov. 22 by UNAIDS. In 2017, three-quarters of people living with HIV (75 percent) knew their HIV status, up […]Continue Reading ...
Scanning electron micrograph of HIV-1 budding (in green) from cultured lymphocyte. This image has been colored to highlight important features; see PHIL 1197 for original black and white view of this image. Multiple round bumps on cell surface represent sites of assembly and budding of virions. Credit: CDC / C. Goldsmith, P. Feorino, E. L. […]Continue Reading ...
Dec 3 2018 Multiple components of the nuclear pore complex and nuclear import machinery enable a protein called human myxovirus resistance 2 (MX2) to inhibit HIV-1 infection, according to a study published November 29 in the open-access journal PLOS Pathogens by Michael Malim of King’s College London, and colleagues. Antibody staining and light microscopy demonstrate […]Continue Reading ...
Young black men who have sex with men (MSM) are 16 times more likely to have an HIV infection than their white peers despite more frequent testing for HIV and being less likely to have unsafe sex, reports a new Northwestern Medicine study. The study was recently published in the Journal of Acquired Immunodeficiency Syndromes. […]Continue Reading ...
From diagnosis of HIV to successful viral suppression: in a rapid communication published in Eurosurveillance today, ECDC and co-authors from Public Health England and The National AIDS Trust summarise the progress towards HIV elimination in 52 countries in Europe and Central Asia. The main issues: diagnosing those who are unaware of their HIV infection and […]Continue Reading ...
Reports have shown that United Kingdom has finally achieved the target numbers when it comes to HIV. The Joint United Nations Programme on HIV/Aids (UNAids) target for 2020 is 90-90-90 which means 90 percent people with HIV would be diagnosed, 90 percent of those diagnosed would receive anti-HIV or anti-retroviral treatment and 90 percent of […]Continue Reading ...
The European Centre for Disease Prevention and Control (ECDC) and the WHO Regional Office for Europe release the latest data on the HIV epidemic in the European Region, marking the 30th anniversary of World AIDS Day. Vytenis Andriukaitis, the European Commissioner for Health and Food Safety, said: “Despite our efforts, HIV still damages the lives […]Continue Reading ...
Credit: CC0 Public Domain A persistent challenge in HIV/AIDS treatment and prevention is medication adherence – getting patients to take their medication as required to get the best results. Currently, a once-daily pill to prevent HIV infection is available. However, adherence to a once-daily regimen can be difficult for some people. Researchers from the UNC […]Continue Reading ...
Dec 4 2018 Tuberculosis is the world’s leading infectious disease and it accounts for one in three deaths from HIV/AIDS, according to the World Health Organization’s 2018 report on TB. This is why on World AIDS Day, Dec. 1, the Forum of International Respiratory Societies (FIRS), of which the American Thoracic Society is a founding […]Continue Reading ...
AIDS patients suffer higher rates of cancer because they have fewer T-cells in their bodies to fight disease. But new research examines why HIV-infected patients have higher rates of cancer–among the leading causes of death among that population–than the general population. Researchers at Case Western Reserve University’s School of Dental Medicine, who lead the study, […]Continue Reading ...
A gene mutation that is believed to have safeguarded some people in 14th century Europe from the bubonic plague today may be protecting HIV patients co-infected with hepatitis C from potentially fatal liver scarring, says a University of Cincinnati (UC) College of Medicine physician-scientist. Kenneth Sherman, MD, PhD, director of the UC Division of Digestive […]Continue Reading ...
EU-funded researchers are leading efforts to develop a functional cure for HIV using innovative therapeutic vaccines to halt the progression of the devastating virus, increase the availability and affordability of treatment, and improve patients’ quality of life. The approach, which has undergone promising proof-of-concept preclinical and clinical trials in the EU-funded IHIVARNA project and is […]Continue Reading ...
In a proof-of-principle study, researchers at Johns Hopkins revealed that certain immune system cells found in the human liver, called liver macrophages, contain only inert HIV and aren’t likely to reproduce infection on their own in HIV-infected people on long-term antiretroviral therapy (ART). ART is a regimen containing combinations of HIV-targeting drugs that prevents the […]Continue Reading ...
A national panel of medical experts is recommending for the first time that clinicians offer daily preventive medication to patients who are at high risk of acquiring HIV/AIDS. The U.S. Preventive Services Task Force estimates that 1.1 million Americans are currently living with HIV. More than 700,000 people have died from AIDS in the United […]Continue Reading ...
- Lund University researchers succeed in obtaining dendritic cells by direct reprogramming
- Breast tumors recruit bone marrow cells to boost their growth, study reveals
- Updated breast cancer screening guideline highlights importance of shared decision-making
- EHR-related stress associated with physician burnout
- AHA: 12-Year-Old Heart Defect Survivor Inspires NFL Player’s Foundation
- Breast cancer patients who take heart drug with trastuzumab have less heart damage
- Providing aid to those humans – and animals – affected by the California fires
- Even without proof, CBD is finding a niche as a cure-all
- Drawing leads to better memory than writing
- Researchers report novel findings on plant hormone
- A Tale of Two Labels
- Triple combination cancer immunotherapy improves outcomes in preclinical melanoma model
- A 14-year-old explains what it’s like to get a new heart
- Team Players Honored with 2018 Baton Awards
- Global report highlights how the changing world is affecting children’s physical activity levels
- Genes play a role in physical activity and sleep
- DDT in Alaskan fish shown to increase risk of cancer
- Laws to curb use of cell phones have greatly reduced fatalities for motorcyclists
- Argenx Provides Detailed Data from Phase 2 Clinical Trial of Efgartigimod in Immune Thrombocytopenia and Phase 1/2 Clinical Trial of Cusatuzumab in Acute Myeloid Leukemia
- University of Maryland doctors treat first breast cancer patients with GammaPod radiotherapy